Clinical Trial Update: Avoiding Surgery in Estrogen Receptor Positive Atypical Ductal Hyperplasia and In-situ Carcinoma Treated With Endocrine Treatment Trial [NA]

View source ↗

Summary

A clinical trial aims to assess whether endocrine therapy can avoid surgery for estrogen receptor–positive atypical ductal hyperplasia and ductal carcinoma in s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ductal Carcinoma in Situ of the Breast

Snippet

Sponsor: Jeong Eon Lee | Conditions: Ductal Carcinoma in Situ of the Breast | NA | Status: NOT_YET_RECRUITING